Market outlook & two stock ideas by Sameet Chavan of Angel Broking

The immediate supports for Nifty are placed around 16,600 and 16,500 while the levels to watch on the upside will be 16,800 and then 17,000 mark

stocks, small cap stocks, mid cap stocks
Sameet Chavan Mumbai
3 min read Last Updated : Aug 30 2021 | 8:25 AM IST
Nifty started last week on a positive note as the global markets recovered, resulting in some positive sentiment. Market participants looked a bit perplexed on Monday, but the broader markets saw buying interest on Tuesday which led to an up move in the index and new highs. Over the next couple of sessions, Nifty consolidated within a range till expiry and it again resumed the momentum on the last day to end the week above 16,700.

In spite of the volatility in the midcap and the smallcap space, the index has managed to register new highs. Meanwhile, the broader markets got their mojo back as many stocks witnessed buying interest from their respective supports. The index continues to be in an uptrend and thus one should continue to trade with a positive bias and avoid taking any contra trades until any reversal is seen. The only concern that we have been highlighting is the banking index which has shown a relative underperformance for so long. But this index is still in a consolidation phase and has not breached its important supports. Hence, there's a good probability of some buying interest emerging in this sector which would then lead to further support to the benchmark. The immediate supports for Nifty are placed around 16,600 and 16,500 while the levels to watch on the upside will be 16,800 and then 17,000 mark. 

Recently, we have seen that when everything looks hunky-dory, there is some volatility due to stock-specific moves. Also how the global markets shape up in the near term due to events can have an impact on our markets. Hence, one should keep track of the global developments and also book timely profits in trading positions.

Stock recommendations:

NSE Scrip Code – CIPLA
View – Bullish
Last Close – Rs. 923.90

Justification: Some stocks from the pharmaceutical space have undergone a corrective phase in the last couple of months and this stock, too, has corrected from its recent highs. However, the medium chart indicates that the trend still continues to be bullish and hence this just seems to be a corrective phase within an uptrend. The price structure has turned positive, and the RSI oscillator has also given a positive crossover and is indicating a positive momentum. Hence, we expect the stock to rebound higher in the near term. We recommend buying the stock at the current market price for a short term target of Rs 960. The stop loss can be placed at Rs 902.

NSE Scrip Code – BPCL
View – Bullish
Last Close – Rs. 471.30

Justification: The stock has consolidated within a range of Rs 469 - 440 in the last couple of months. This entire consolidation was around its ‘89 DEMA’ support and now there are signs of a breakout from this consolidation on the higher side. The ‘Bollinger Bands’ which had narrowed recently have started to widen and prices are riding the upper end of the band which is a positive sign. Hence, we recommend buying the stock for a short term price target of Rs 496. The stop loss needs to be maintained at Rs 456.

============================================================
Discalimer: Sameet Chavan is Chief Analyst- Technical & Derivatives, Angel Broking. Views expressed are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Market OutlookMarket technicalsStock ideasStock PicksAngel BrokingNifty50technical callsStocks calls

Next Story